ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics Inc (QB) (NWBO)

0.264
-0.0062
(-2.29%)
Closed November 02 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.264
Bid
0.26
Ask
0.2629
Volume
2,809,310
0.2575 Day's Range 0.27285
0.2531 52 Week Range 0.929
Market Cap
Previous Close
0.2702
Open
0.2711
Last Trade
64
@
0.2629
Last Trade Time
Financial Volume
$ 744,960
VWAP
0.265175
Average Volume (3m)
2,271,438
Shares Outstanding
1,248,237,358
Dividend Yield
-
PE Ratio
-3.29
Earnings Per Share (EPS)
-0.05
Revenue
1.93M
Net Profit
-64.37M

About Northwest Biotherapeutics Inc (QB)

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is i... Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. The Company operates in the United States, the UK, Germany and Canada and is incorporated in Delaware, USA. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Northwest Biotherapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NWBO. The last closing price for Northwest Biotherapeutics (QB) was $0.27. Over the last year, Northwest Biotherapeutics (QB) shares have traded in a share price range of $ 0.2531 to $ 0.929.

Northwest Biotherapeutics (QB) currently has 1,248,237,358 shares outstanding. The market capitalization of Northwest Biotherapeutics (QB) is $337.27 million. Northwest Biotherapeutics (QB) has a price to earnings ratio (PE ratio) of -3.29.

NWBO Latest News

Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher

Imagine a new weapon in the fight against cancer, a personalized therapy that utilizes the body's own immune system to attack tumors. Science fiction? This biotech company just secured exclusive...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.016-5.714285714290.280.29510.257515029060.28198848CS
4-0.0559-17.47421069080.31990.3290.253119504550.29004913CS
12-0.0421-13.75367526950.30610.39560.253122714380.31640607CS
26-0.205-43.7100213220.4690.540.253120555700.36604882CS
52-0.5048-65.66077003120.76880.9290.253119014170.49044669CS
156-0.766-74.36893203881.032.050.253121688050.70841926CS
2600.0145.60.252.540.00523894950.83872628CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BLIAQBB Liquidating Inc (CE)
$ 0.001
(99,900.00%)
102.03k
ERHEERHC Energy Inc (CE)
$ 0.001
(99,900.00%)
5.11M
GAPJGolden Apple Oil and Gas Inc (CE)
$ 0.001
(99,900.00%)
130
VIPZVIP Play Inc (PK)
$ 0.75
(62,400.00%)
300
FFRMFFuture Farm Technologies Inc (CE)
$ 0.000101
(10,000.00%)
1.25k
REPCFRepliCel Life Sciences Inc (CE)
$ 0.000001
(-99.98%)
2.5k
AHPIQAllied Healthcare Products Inc (CE)
$ 0.000001
(-99.50%)
1.16k
JUVAFJuva Life Inc (CE)
$ 0.000001
(-99.00%)
300
DXBRFBellRock Brands Inc (CE)
$ 0.000001
(-99.00%)
193.88k
MNGGMining Global Inc (PK)
$ 0.000001
(-99.00%)
4.7M
NSAVNet Savings Link Inc (PK)
$ 0.0006
(-68.42%)
1.1B
HMBLHUMBL Inc (PK)
$ 0.0003
(50.00%)
260.3M
RDARRaadr Inc (PK)
$ 0.001
(-9.09%)
214.52M
NNAXNew Momentum Corporation (PK)
$ 0.0006
(0.00%)
194.37M
ASIIAccredited Solutions Inc (PK)
$ 0.0009
(0.00%)
138.32M

NWBO Discussion

View Posts
exwannabe exwannabe 42 seconds ago
Blame Phase V as they brought NWBO onto OTC not management.
I seriously doubt any minor hit piece like that mattered compared to:

. LL letting slip that the primary PFS endpoint was no longer what they were looking for in the P3.
. FDA placing an unexplained screening hold on the trial.
. LP going to war with the only serious investor NWBO even had.
. The MFN terms with Cognate run amok.

But sure, blame it on some minor blog that nobody has herd of.
👍️0
CrashOverride CrashOverride 2 minutes ago
Given current depressed prices it's obvious there will be massive retail and institutional buying once we get news from MHRA.
👍️0
CrashOverride CrashOverride 7 minutes ago
Do you think investors will pay $10 a share now before approval? No.

Blame Phase V as they brought NWBO onto OTC not management.

I am envious of anyone who's able to buy NWBO at such low prices.
👍️0
dennisdave dennisdave 7 minutes ago
Hiring process should have started already, why haven’t they if approval is coming within months and they plan to have $100M in sales year one even without reimbursement?
haven't you heard FeMike DCVAXL is "selling itself" 🤣
👍️0
dennisdave dennisdave 10 minutes ago
NWBO could stave off the wolves by taking out a five million dollar loan with no payments due until it matures in two years. With the opportunity for the lenders to be paid back with .30 cent shares at maturity even when the stock might be much much higher.

How on earth is providing the option to convert $5 million into 16.7 million in two years, when hopefully shares are at $10 or higher, a good deal for NWBO? Its not.
There are three things I take from this terrible loan agreement
1. NWBO is not counting on earth-shattering news this year.
2. They are, financially, with their backs against the wall to have to agree to these terrible terms set by a large shareholder (Thermo or Bigger?)
3. Two years until maturity to me seems they don't expect to be acquired in the next two years, which does not surprise me
👍️0
learningcurve2020 learningcurve2020 13 minutes ago
You don't need to be an expert to know this Friday after the bell news release is lousy.  I may have gotten it wrong calling .19 before year end. Look like as early as next week now.  
👍️0
CrashOverride CrashOverride 13 minutes ago
Shorts collapsed the stock price making credit markets inaccessible for management. Should you direct anger at such manipulation rather than blaming management which brought us to cusp of global approval? Yes.

I am glad angel investors continue to see value in the company. Obviously post approval we will be in a different situation as institutional investors and credit markets will be much easier to access on favorable terms.

I am very excited about the last two months of 2024 as they should being monumental news for Northwest Biotherapeutics shareholders.
👍️0
polska polska 51 minutes ago
How about a little cheese with your whine?
👍️0
Zadie420 Zadie420 1 hour ago
DOC- I think the first year we will have more than 1000 patients for treatment. The second year will increase accordingly. 600 number is very low ball here. I am hoping by the end of first year we got another approval from other jurisdictions
👍️0
FeMike FeMike 1 hour ago
It’s not just number of employees. Its accounting rollout, distribution, product launch, marketing plan, contract negotiations, distractions with R&D and the amount of time all of those things take.

How is that number you come up with impacted by a digitized process overseen by a company that Linda owns
This would be a major negative, considering she has no idea what she is doing.
sales will not be a problem due to approval news that most all neurosurgeons will be kept up to date on?; ).
That is simply not how the process works. This statement kinda makes it look like you don’t really know what you’re talking about.
Linda said they would add employees at NWBO so with this in mind how many?
Hiring process should have started already, why haven’t they if approval is coming within months and they plan to have $100M in sales year one even without reimbursement?
👍️ 3
Poor Man - Poor Man - 1 hour ago
This is more of the same. There doesn’t appear to be any coherent funding philosophy or strategy. The balance sheet is littered with ad hoc financial arrangements from both Penny-stock lenders and the company’s bench of angel investors. And unfortunately this new loan just fits that exact description. Will be interesting to read the Loan Agreement.

The window for incrementally buying shares is between December and into early next year in my opinion. I said this yesterday even before learning about the new loan, November is shaping up to be a rough month.
👍️0
Doc logic Doc logic 2 hours ago
FeMike,

How many employees does NWBO need for 600 patients worldwide including those tied to clinical trials that NWBO is seeking self pay or partner sponsored patients for? How is that number you come up with impacted by a digitized process overseen by a company that Linda owns and will be held accountable for when sales will not be a problem due to approval news that most all neurosurgeons will be kept up to date on?; ). Linda said they would add employees at NWBO so with this in mind how many? Best wishes.
👍️ 1
JTORENCE JTORENCE 2 hours ago
SparklingNavigator24 Exactly right, she's a gifted carnival barker.
👍️0
Perk_Idaho Perk_Idaho 2 hours ago
Ya, take LC's word for it. He is an expert on running and financing business ops, thats why he is here on a Saturday running his mouth. Hahhahaa. Too funny.
👍️0
JTORENCE JTORENCE 2 hours ago
bas2020 Do you always reply to a message when it is not directed to you. Gettin pretty lonely out there in the forest when you can't see the forest thru the trees.. Been there and done that ,but praise the Lord not anymore.
👍️0
wimike wimike 2 hours ago
That would dilute for approximately 37 million shares if it were simple interest and not compounded but still very close. I guess it is a small price to pay if we hit pay dirt. Considering how many shares we have outstanding I can live with it. We have no choice anyway but to ride it out or sell.
What worries me Flip is that we are getting closer to a decision, and the price keeps sinking. I never thought it would have gone all these years. My first RMD is due NLT 4/01/2025 and then another by the year-end 12/31/2025. Some of it will have to come from NWBO stock, that is, if there is any MC left. Or maybe by then, it will be taking off. It's a tough situation.
As I get older the dream of riches from this stock becomes less important. When your lifetime partner of 51 years is facing lung cancer and we find out tomorrow what will happen next and what stage it is you realize things like this become so unimportant. All the arguing back and forth is so petty. we both get a lung scan every year so we both hope it is in its early stage where they can operate and maybe some radiation will be successful. I wish they would approve some of the new drugs and combinations so they are less toxic to the body. We need faster approvals with maybe warnings.
Good luck, everyone. This will be the last biotech I invest in, as my record is terrible. I will stick to what I know best.
👍️ 3
Doc logic Doc logic 2 hours ago
learningcurve2020,

That lousy $5,000,000,000 is the kind that is supposed to lead to a death spiral and yet Linda has been doing this continually except during the Woodford era. I’d say that’s proof she is not going to sink the ship as it comes to port and there are still no listed big owners. Interesting huh?; ). Best wishes.
👍️0
Investor082 Investor082 2 hours ago
Yes, I agree. He has been trading this stock and also trapping retail into buying or not selling with his gaslighting skills. No other reason to back the same management team for a decade or more if you have constantly been losing value on your investment (to the tune of 80-90%, if not more). Particularly with all the lies management has spewed and lethargic execution over the years. He is a trader!

I worry for folks invested in OTLK, where he has been gaslighting.
👍 4
FeMike FeMike 2 hours ago
I guess I am just asking if you think that 600 patients paying $150,000 for treatment is doable within the first year after approval.

I don’t think that number is outside the realm of possibility, but I don’t think it likely at all.

NWBO has no infrastructure for scaling of that magnitude that quickly.

I think if they can get quarterly revenue to ~10ish million by the end of year one it’ll show they’re on a proper growth curve and can hit 1000+ patients/year by year 3.
👍️0
Doc logic Doc logic 2 hours ago
FeMike,

I guess I am just asking if you think that 600 patients paying $150,000 for treatment is doable within the first year after approval. That was my estimate of year one revenue post approval that Investor082 thinks is too rich. I think revenue from small clinical trials will stream in as part of this as well as worldwide self pay patients willing to pay for combo type protocols. Set aside funding will also likely be available especially if Dr. Keyoumars Ashkan has anything to say about it. I expect longer term reimbursement from NICE to happen (about your one year mark) as costs drop from introduction of Flaskworks, approval of Poly ICLC with L, quality life years are nearly maxed out and as volume picks up. Combos will provide a reimbursement bump up as well once those results are shared but proceeds will need to be shared with a combo partner or adjuvant maker so I assume pricing models for combos will be critical for all parties. Best wishes.
👍️0
FeMike FeMike 2 hours ago
“Thermo's pumping”? Sure, whatever makes you happy :)
Uh huh…so if not pumping, what would you call it when someone who claims to be a financier of multiple installments of millions of dollars for a public startup and has much more detailed conversations with management than retail to the point where he alludes he may be subject to an NDA, gets on a social media message board and posts:
Not ready to say anything yet but I keep having dreams where April Showers is playing in the background. Probably should ask a psychologist what it all means.
I've also heard some other commentary (not from the company) that makes me slightly more bullish on how the MAA will be received.

Last year you predicted April, May, June, July and September for MAA submission based on your “in depth knowledge of the process”.

I’m not a rocket appliance but if that’s not pumping, then Nemesis must have never been bashing either, because it doesn’t get much more extreme than that.

I respect you Thermo. I think you’ve made a ton of money off of Linda Powers. Pumping and flipping. I’m not gonna bash you because you’re definitely doing way better than me.

But you absolutely were a pumper. I’m guessing you backed off for a particular reason.
👍️ 2 💯 1
learningcurve2020 learningcurve2020 2 hours ago
Come on Ex!  Look at the history and the governance.  We knew none of it was going to happen but Thermo's out their selling the company while making no demands on management to benefit retail.  
👍️0
learningcurve2020 learningcurve2020 2 hours ago
BS. I've already pointed out Geron and other companies who didn't need to go under the forever cone of silence while waiting on regulators.  She could've easily changed the terms of the loan start due date with a little sweetener (and we know she just loves those sweeteners!). 
👍️0
dennisdave dennisdave 3 hours ago
ok well we will see
👍️0
VikingInvest VikingInvest 3 hours ago
I never said they would stop and let it run. I said in my opinion, this could happen, but hardly something I would bet on. It just seemed like a good time for them to stop if they are continuing this to keep the damage part of the lawsuit lower. I'm not inside their minds, so don't know if this is their strategy. I hope it is.
👍 1
RobotDroid RobotDroid 3 hours ago
SpankingNav, your clueless.
👍️0
SparklingNavigator24 SparklingNavigator24 3 hours ago
The SP has been manipulated each and every day. We are very close to approval.
👍️ 3
RobotDroid RobotDroid 3 hours ago
Yeah, for herself.
👍️0
RobotDroid RobotDroid 3 hours ago
It's a VERY BAD sign. Means no news in 2024.
👍️0
SparklingNavigator24 SparklingNavigator24 3 hours ago
Perhaps you’re the moron, it’s call collusion and yes this is where you would discourage potential investors. Is it your boss saying “Don’t Worry…”?
👍️ 1
exwannabe exwannabe 3 hours ago
These guys make money in other ways. I'm sure they get the real details on the internal plans before putting down their money. It doesn't hurt them to pump some optimism on this board
FWIW, my opinion on "these guys" aligns with yours in general. This caused me a few brushups Thermo early on where I was projecting my opinion of "these guys" onto Thermo.

As time went by, I decided he kind of was as a straight shooter and not like the general pack you are talking about.

This is not to say I agree with him on this particular stock analysis of course
👍️ 2
SparklingNavigator24 SparklingNavigator24 3 hours ago
If there is one thing LP got an “A” in, is the ability to raise funds.
👍 1
GoodGuyBill GoodGuyBill 3 hours ago
You know it...lol. Shameful.

LOL. "Check back with me in a year." You'll be long gone within a month, after approval... re-assigned to a new stock to trash. 👿☠️
👍️0
dennisdave dennisdave 3 hours ago
Hopefully not. Hopefully not.
pfffff at this point I just hope we stay over 80 cents after UK approval
👍️0
learningcurve2020 learningcurve2020 3 hours ago
Thermo couldn't even throw them $1,500 and demand a new website. 
👍️0
meirluc meirluc 3 hours ago
SparklingN, you are most likely right that the SEC is pandering to
the billionaires but that will not change regardless of the results of this
election. At worst, the election results may increase the SEC's favoring
the billionaire class but that agency has no input on decisions of State courts.
Consequently, I believe that the election results will not sway the judge's decision.
Most likely, the judge has not finished reviewing the case but hopefully will soon do
just that. Furthermore, Cohen/Milstein would not have taken the case on contingency
if they suspected that there is a good chance that election results could be used to
nullify or overturn a MTD denial decision that is issued by a state court.
👍️ 1
flipper44 flipper44 3 hours ago
Because she doesn’t know one way or the other if she’ll get approval before the prior loan’s first payment comes due on December14, and bears were trying to destroy the PPS leading towards that event, exploiting nwbo’s required silence prior to an MHRA decision? And financiers don’t get any deals this week from shoving the price down further?
👍️ 4
learningcurve2020 learningcurve2020 3 hours ago
Maybe with a $100M raise but not with a lousy $5M loan.  Just the opposite actually. 
👍️0
NotSure2 NotSure2 3 hours ago
Im thinking that I might have been too optimistic in my timeline approval :(

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174698709

(been the closest in prediction Journal, then validation, and so far submission, always too optimistic unfortunately)

Lets hope this time I am bang on for a February 2025.

Unfortunately I believe we might fall under the 508 days average drug to approval statistic. For NWBO it would mean ~ 550-600 days. So summer to fall 2025. Not saying this is the case, but might be. Hopefully not.
👍️0
learningcurve2020 learningcurve2020 3 hours ago
Precisely.  So obvious to anyone without the blinders.  
👍️0
Bright Boy Bright Boy 3 hours ago
Part of the program in a potential negotiation is letting them know you can raise money and to dispel the notion that they can wait you out. Remember that.

Cheers.

BB
👍️ 7
dennisdave dennisdave 3 hours ago
btw if you are again, as I did with you great fun lol, claiming that Im a short and a bear then I can tell you that I wish I was.
I wish I shorted NWBO as smart-ass Thermo did when it was at $2.2 but alas I never sell shorted NWBO stock only long unfortuntalely.
👍️ 1
dennisdave dennisdave 4 hours ago
Maybe because Linda Powers explained at the ASM those deals would be announced when the deals were completed, and maybe the deals aren’t completed until approval (apparently this is what she meant by “cemented”), and maybe bears are attacking while nwbo is required to remain silent during the approval process.


yes so my question still stands then.
why would powers allow the conversion of the loan at 30 cents if NWBO is a completely different company after UK approval and has arranged nondilutive financing, in the next 4 to 8 weeks?
I have always said that I believe that NWBO can get finances for joint trials on the prerequisite of approval, its shitty loan deals like this, that shake my belief in that
👍 1
JFR161162 JFR161162 4 hours ago
The last comment from Vikinginvest is very clear: the hedge funds and their minions will let the stock go upon approval and I suspect they're gonna be buyers on the way up.
Stock should close the $2,70 gap of May 10th 2022.
👍️ 2
flipper44 flipper44 4 hours ago
Dennisdave asked: “why would NWBO even consider a loan if they have arranged nondilutive financing for joint trials as promised by Powers?”

Maybe because Linda Powers explained at the ASM those deals would be announced when the deals were completed, and maybe the deals aren’t completed until approval (apparently this is what she meant by “cemented”), and maybe bears are attacking while nwbo is required to remain silent during the approval process.
👍 9 💯 3
dennisdave dennisdave 4 hours ago
how the hellll is this loan at this point in time against these mwah terms "a very favorable deal" IF NWBO expects nondilutive financing right after UK approval?
why would NWBO even consider a loan if they have arranged nondilutive financing for joint trials as promised by Powers?

Worse. Why would NWBO agree on the terms of converting to stocks at 30 cents if they expect the share price to be x5 of that right after UK approval within the next 6-8 weeks? Please explain that to me.

Its nuts to call this loan "a very favorable deal" IF NWBO expects to be in a completely different place in the next 4-8 weeks

That is why I think the SP has been tanking over the last 1-2 weeks

Ofcourse NWBO will be a different company after UK approval which makes Powers a terrible negotiator when it comes to this loan.
👍️ 3 💯 1
theorysuit theorysuit 4 hours ago
These guys make money in other ways. I'm sure they get the real details on the internal plans before putting down their money. It doesn't hurt them to pump some optimism on this board
👍 1 👎️ 1
CaptainObvious CaptainObvious 4 hours ago
That was more optimistic than I thought you might be.
👍️0
Rh2022 Rh2022 4 hours ago
Appreciate it, Thermo.
👍️0
learningcurve2020 learningcurve2020 4 hours ago
Unchanged is right! Same old NWBO dragging out everything but the private manufacturing start ups.  At first I thought maybe you were legitimate but soon realized your lack of interest in improving governance, management communications, and clawing back the private businesses, meant you're not serious.  I'm sure you've already done well for yourself. Congrats.  
👍️ 3 💯 1 🤧 1 🫵 1

Your Recent History

Delayed Upgrade Clock